- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 24.02. | FDA works to reverse layoffs, rehire lost staff: reports | ||
| 24.02. | Entrada's 2-year ordeal ends as FDA lifts hold on DMD drug | ||
| 24.02. | Ex-CDER chief Patrizia Cavazzoni becomes Pfizer's chief medical officer | ||
| 24.02. | FDA approves Medtronic's adaptive deep-brain stimulator for Parkinson's disease | ||
| 24.02. | OS Therapies sets up subsidiary to seek ADC joint ventures with US, China peers | ||
| 24.02. | Pfizer inks deal to test Summit's white-hot bispecific with ADCs | ||
| 24.02. | Sanofi shows how $500M bowel disease bet compares to Merck and Roche's rival assets | ||
| 24.02. | VC firm Kineticos launches biotech to develop fresh approach to antibiotic resistance | ||
| 21.02. | Deputy director of FDA's CBER departs amid mass exodus at federal health agencies | ||
| 21.02. | Roche rolls out new DNA 'sequencing-by-expansion' approach | ||
| 21.02. | Procedural 'loophole' leaves NIH grants frozen, despite orders from federal judge: reports | ||
| 21.02. | MeiraGTx gene therapy allows 11 blind children to see as biotech eyes accelerated approval | ||
| 21.02. | Concentra curveball offer throws Acelyrin merger with Alumis into doubt | ||
| 20.02. | US biotech Hookipa retracts merger plans with UK company | ||
| 20.02. | Heart monitoring patch maker VitalConnect raises $100M | ||
| 20.02. | Illumina maps out entry into spatial transcriptomics | ||
| 20.02. | German research institute teams up with Barbados to improve cardiometabolic treatments for Black individuals | ||
| 20.02. | IconOVir, 4 years on from flashy launch, sells oncolytic virus to UroGen for $4M in stock | ||
| 20.02. | Incyte pens $885M biobucks AI pact to use Genesis' GEMS to develop new drugs | ||
| 19.02. | It's curtain close for Spotlight: Gene editing biotech shutters | ||
| 19.02. | Deep Track nominates candidates for Dynavax's board, launching proxy fight to end company's 'empire-building' strategy | ||
| 19.02. | Altitude Lab sources funding, lab space for biotechs concerned about fate of NIH grants | ||
| 19.02. | Cabaletta's CAR-T shows 'robust benefit' in lupus patients, teeing up registrational trial plans | ||
| 19.02. | Siemens Healthineers plans 'mega depots' to bolster US supply chain amid 'geopolitical uncertainties' | ||
| 19.02. | Ascletis' swift surge into obesity continues with competitive oral GLP-1 data |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
